Back to Search
Start Over
DNA Methylation of CD70 Promoter in Juvenile Systemic Lupus Erythematosus.
- Source :
- Fetal & Pediatric Pathology; Feb 2022, Vol. 41 Issue 1, p58-67, 10p
- Publication Year :
- 2022
-
Abstract
- Epigenetic alterations in pathogenesis of systemic lupus erythematosus (SLE) have gained more attention recently in adults. We assessed the methylation of CD70 promoter, a costimulatory molecule on T cells, in juvenile SLE (JSLE), and compared this to that found in controls and the literature of adult SLE patients. DNA methylation status was evaluated on peripheral blood from JSLE patients and healthy controls. Twenty-five patients with JSLE and 24 healthy controls were compared. JSLE patients had lower unmethylated CpG islands compared to the control group (mean ± SD; 0.78 ± 0.42 vs 10503.80 ± 39796.95). However, the difference was not significant (P-value; 0.22). Despite hypomethylation of CD70 gene promoter in CD4+ T-cells from adult patients with SLE, no statistically significant differences observed in patients with JSLE compared with healthy controls. This may suggest a mechanism different in JSLE patients than in adults. [ABSTRACT FROM AUTHOR]
- Subjects :
- SYSTEMIC lupus erythematosus
DNA methylation
METHYLATION
T cells
Subjects
Details
- Language :
- English
- ISSN :
- 15513815
- Volume :
- 41
- Issue :
- 1
- Database :
- Complementary Index
- Journal :
- Fetal & Pediatric Pathology
- Publication Type :
- Academic Journal
- Accession number :
- 155083029
- Full Text :
- https://doi.org/10.1080/15513815.2020.1764681